TB Dispensary Arkhangelsk, Northern Russia
In Russia, MSF is collaborating with health authorities and academic partners in the Arkhangelsk and Vladimir regions to reduce the burden of drug-resistant tuberculosis.

Our teams are working on a study in collaboration with the Ministry of Health, which aims to prove the effectiveness of all-oral novel short-course regimens for patients with DR-TB. In 2021, more than 60 people were enrolled into the study in the regions of Arkhangelsk and Vladimir. By the end of 2021, the first patients completed their treatment and started the follow-up stage.

In Moscow and St. Petersburg, we continue our partnership with two community-based NGOs, offering healthcare to vulnerable people, including those living with HIV. The current project has been running since 2020, and has expanded its support from COVID-19 to additional infectious diseases.

Since the war in Ukraine began, approximately 1.5 million people have fled the country, of whom more than 53,000 have sought safety in Russia. We have set up teams in Russia to explore the humanitarian and medical needs of refugees and displaced people.  

Our activities in 2021 in Russia

Data and information from the International Activity Report 2021.

MSF in Russia in 2021 In Russia, Médecins Sans Frontières (MSF) works with the health authorities in Arkhangelsk and Vladimir regions to reduce the burden of drug-resistant tuberculosis (DR-TB) and improve treatment for the disease.
media:orange_logic_image:b5876b5a-8bd3-482e-9c4e-d98e45beac64

After several years designing our operational research study on new treatment regimens for DR-TB, we started to enroll our first patients in 2021. The aim of the collaborative study is to prove the effectiveness of novel, all-oral, short-course regimens for patients with DR-TB and provide evidence for future developments in TB policy in Russia.

In 2021, more than 60 people were enrolled into the study in Arkhangelsk and Vladimir regions. By the end of the year, the first patients had completed their treatment and started the follow-up stage.

In Moscow and St Petersburg, MSF continued a partnership with two community-based NGOs providing prevention and treatment of HIV and hepatitis C for at-risk groups. The current project has been running since 2020, when it started to support people with COVID-19, and has been expanded to include care for other infectious diseases.

In 2021, in collaboration with MSF, one of our partner organisations set up a fixed medical unit in St Petersburg, providing medical consultations to people from vulnerable groups. We also ran training sessions on mental health and burnout prevention for the medical and patient support team.
 

 
Humanitarian Action’s Dr Olga talking to the patients
Russia

Supporting people displaced by the conflict in Ukraine to Russia

Project Update 20 Sep 2022
 
Tuberculosis treatments yield promising results in the Chechen Republic
Russia

Tuberculosis treatments yield promising results in the Chechen Republic

Voices from the Field 10 Nov 2017
 
Russia

MSF closes mental health programme in Ingushetia

Project Update 23 Nov 2012
 
Russia

Emergency response to people affected by wood fires in Russia

Project Update 12 Aug 2010
 
Russia

Hope for peace in Ingushetia has given way to despair

Project Update 29 Sep 2009
 
Russia

Geneva court rules in favour of MSF in Dutch government case

Press Release 27 Feb 2008

Contact us

TB treatments yield promising results in the Chechen Republic
MSF Moscow

16 Malaya Dmitrovka street,
127006 Moscow,
Russian Federation